Home › Trials › NCT07168122
Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Normal ranges and diagnostic cut-offs for salivary cortisol

Official title: Study for Reference Intervals and Optimal Cut-offs for Salivary Cortisol

Run by Shanghai 6th People's Hospital · NCT07168122 · Data updated 2026-11-12

This project will test two saliva cortisol methods — a lab LC‑MS assay and a rapid fluorescence immunoassay — to find normal ranges and the best diagnostic cut-offs for adults with suspected Cushing syndrome or adrenal insufficiency.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment220 (estimated)
SponsorShanghai 6th People's Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedJune 30, 2027
Study endsDecember 31, 2027
Registry record updatedSeptember 11, 2025
Trial IDNCT07168122 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include healthy adults aged 18–60 with BMI 18.5–24.9 for establishing reference ranges, and adults with confirmed or suspected Cushing syndrome or adrenal insufficiency for determining diagnostic cut-offs.

Probably not a fit

People outside the age or BMI criteria, pregnant or lactating women, those with chronic diseases, heavy alcohol use, or conditions/medications that alter cortisol levels are unlikely to benefit from the study findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Saliva testing offers a non-invasive way to measure biologically active free cortisol but is challenged by very low concentrations and limited detection methods. This observational work will apply an immunomagnetic‑bead LC‑MS assay with simplified preparation and a fluorescence immunoassay designed for point‑of‑care use. The team will establish reference intervals in a healthy adult population and determine optimal diagnostic cut-offs using samples from patients with Cushing syndrome and adrenal insufficiency. Comparing the two methods aims to support clinical adoption by defining reliable thresholds and practical workflows.

Why it matters

Potential benefit: If successful, clinicians could use accurate, non-invasive saliva tests — including a rapid point-of-care option — to help diagnose and screen for Cushing syndrome and adrenal insufficiency.

How similar studies have gone: Salivary cortisol measured by LC‑MS is already used in research and some clinical settings, but the simplified LC‑MS workflow and the fluorescence point‑of‑care immunoassay are newer and less broadly validated.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Healthy Volunteers:

Inclusion Criteria:

1. Age ≥ 18 and ≤ 60 years old;
2. Body mass index (BMI) ≥ 18.5 and ≤ 24.9 kg\*m\^-2;
3. No previous history of chronic diseases such as hyperglycemia, hypertension, dyslipidemia, coronary heart disease and stroke;
4. Normal glucose regulation, defined as: fasting blood-glucose \< 5.6 mmol/L, 2-hour blood-glucose after glucose load \< 7.8 mmol/L, and glycated hemoglobin (HbA1c) \< 5.7%.

Exclusion Criteria:

1. Liver or kidney dysfunction, alanine aminotransferase (ALT) or aspartate aminotransferase (AST) or direct bilirubin higher than 1.5 times the upper limit of normal, or serum creatinine \>115 μmol/L;
2. Pregnancy or lactation women, or people with cancer or mental illness;
3. Factors affecting cortisol levels, including hypothalamus-pituitary-adrenal axis disease, autoimmune disease (systemic lupus erythematosus, rheumatoid arthritis, etc.), diagnosed mental disease, Alzheimer's disease, alcoholism (alcohol \> 60 g/d for male, \>40 g/d for women) and corticosteroid therapy in the past 3 months (females with contraceptives or estrogen);
4. Factors affecting saliva collection, such as serious oral problems (oral ulcers, gingival bleeding);
5. Night shift workers, who are awake from 11:00 PM to 7:00 AM;
6. Acute infection (body temperature ≥ 37.3 ℃ or C-reactive protein \> 50 mg/L).

Cases:

Inclusion Criteria:

1. Aged 18 to 80 years old;
2. Patients with suspected Cushing's syndrome or adrenal insufficiency.

Exclusion Criteria:

1. Corticosteroid therapy within the last 6 weeks;
2. Acute infection;
3. Severe oral conditions;
4. Severe liver and kidney dysfunction;
5. Alcoholism, depression, or other psychiatric disorders.

Where it's running

  • Shanghai Sixth People's Hospital
    Shanghai, Shanghai Municipality, China     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Healthy Adult 35Cushing Syndrome 15Adrenal Insufficiency 13Shanghai 6th People's Hospital 33
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.